Tropicana Slim merupakan salah satu brand yang terkenal dengan produk-produk rendah gula, dan varian Nutty Chocolate ...

Merck’s Keytruda, with more than 40 approved indications, hasn’t yet been able to crack specifically into ovarian cancer. But with promising early results from a phase 3 study in certain ...

As has been the case for several quarters now, Merck KGaA’s life science business continues to serve as a weathervane for the broader biopharma industry. For the full year, Merck now expects ...

Merck KGaA, the German science and technology group, trimmed its profit forecast, citing a weakening US dollar and uncertainty around global tariffs. The stock tumbled. The company now expects ...

Merck KGaA (Merck) has moved to strengthen its position in oncology and rare diseases with a $3.9bn agreement to acquire SpringWorks Therapeutics. Under the deal, Merck will pay $47 per share in ...

May 14 (Reuters) - The U.S. Food and Drug Administration said on Wednesday it has approved the expanded use of Merck's (MRK.N), opens new tab cancer drug to treat two rare types of adrenal gland ...

Drugmaker Merck said Tuesday it is investing $1 billion in a new Delaware plant to expand domestic production as it prepares to deal with President Trump’s tariffs. The new facility will produce ...

Caroline Litchfield; Chief Financial Officer, Executive Vice President; Merck & Co Inc Dean Li; Executive Vice President, President - Merck Research Laboratories; Merck & Co Inc Thank you for ...

Merck & Co. said it expects to lose $200 million to already-announced tariffs in 2025 amid a roiling trade war between the US and China. The estimate doesn’t account for the possibility that ...

FDA approved Merck's Welireg as the first oral therapy for advanced pheochromocytoma or paraganglioma (PPGL). In the LITESPARK-015 trial, Welireg showed a 26% ORR and a 20.4-month median duration ...

Pharmaceutical company Merck (NYSE:MRK) is set to announce its first quarter earnings result on Thursday, April 24th, before the opening bell. Analysts on consensus expect the company to report ...